Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward

被引:106
作者
Bryant, Juliet E. [1 ]
Azman, Andrew S. [2 ,3 ]
Ferrari, Matthew J. [4 ,5 ]
Arnold, Benjamin F. [6 ]
Boni, Maciej F. [4 ,5 ]
Boum, Yap [7 ]
Hayford, Kyla [2 ]
Luquero, Francisco J. [8 ]
Mina, Michael J. [9 ,10 ]
Rodriguez-Barraquer, Isabel [11 ]
Wu, Joseph T. [12 ]
Wade, Djibril [13 ]
Vernet, Guy [14 ]
Leung, Daniel T. [15 ]
机构
[1] Fdn Merieux, Lab Emerging Pathogens, Lyon, France
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Med Sans Frontieres, Geneva, Switzerland
[4] Penn State Univ, Dept Biol, University Pk, PA 16802 USA
[5] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA
[6] Univ Calif San Francisco, Francis Proctor Fdn 1, San Francisco, CA 94143 USA
[7] Epicentre, Yaounde, Cameroon
[8] Epicentre, Paris, France
[9] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA
[10] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA
[11] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[12] Univ Hong Kong, Sch Publ Hlth, LKS Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Peoples R China
[13] Inst Rech Sante Surveillance Epidemiol & Format I, Dakar, Senegal
[14] Inst Pasteur, Bangui, Cent Afr Republ
[15] Univ Utah, Sch Med, Div Infect Dis, Salt Lake City, UT 84112 USA
关键词
D O I
10.1126/sciimmunol.abc6347
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of antibody tests will critically depend on the use case (individual level versus population level).
引用
收藏
页数:4
相关论文
共 10 条
[1]   Integrated Serologic Surveillance of Population Immunity and Disease Transmission [J].
Arnold, Benjamin F. ;
Scobie, Heather M. ;
Priest, Jeffrey W. ;
Lammie, Patrick J. .
EMERGING INFECTIOUS DISEASES, 2018, 24 (07) :1188-1194
[2]  
Diggle P. J., 2011, EPIDEMIOL RES INT, V2011, P608719, DOI DOI 10.1155/2011/608719
[3]   Basic methods for sensitivity analysis of biases [J].
Greenland, S .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1996, 25 (06) :1107-1116
[4]   Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period [J].
Kissler, Stephen M. ;
Tedijanto, Christine ;
Goldstein, Edward ;
Grad, Yonatan H. ;
Lipsitch, Marc .
SCIENCE, 2020, 368 (6493) :860-+
[5]   Antibody testing will enhance the power and accuracy of COVID-19-prevention trials [J].
Lipsitch, Marc ;
Kahn, Rebecca ;
Mina, Michael J. .
NATURE MEDICINE, 2020, 26 (06) :818-819
[6]   Use of serological surveys to generate key insights into the changing global landscape of infectious disease [J].
Metcalf, C. Jessica E. ;
Farrar, Jeremy ;
Cutts, Felicity T. ;
Basta, Nicole E. ;
Graham, Andrea L. ;
Lessler, Justin ;
Ferguson, Neil M. ;
Burke, Donald S. ;
Grenfell, Bryan T. .
LANCET, 2016, 388 (10045) :728-730
[7]   Dengue pre-vaccination screening and positive predictive values [J].
Rodriguez-Barraquer, Isabel ;
Salje, Henrik ;
Cummings, Derek A. T. .
LANCET INFECTIOUS DISEASES, 2019, 19 (02) :132-134
[8]  
Tan W., 2020, Infect Dis (except HIV/AIDS), DOI DOI 10.1101/2020.03.24.20042382
[9]   Performance Characteristics of a Multiplex Flow Immunoassay for Detection of IgG-Class Antibodies to Measles, Mumps, Rubella, and Varicella-Zoster Viruses in Presumptively Immune Health Care Workers [J].
Theel, Elitza S. ;
Sorenson, Marisa ;
Rahman, Crystal ;
Granger, Dane ;
Vaughn, Andrew ;
Breeher, Laura .
JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (04)
[10]  
Wu F., 2020, NEUTRALIZING ANTIBOD, DOI [10.2139/ssrn.3566211, 10.1101/2020.03.30.20047365]